[HTML][HTML] Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
…, YJ Bignon, N Uhrhammer, JP Peyrat, P Vennin… - PLoS …, 2011 - journals.plos.org
Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization
is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of …
is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of …
Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary …
…, I Farre, JP Peyrat, S Taieb, C Adenis, P Vennin - Gynecologic …, 2011 - Elsevier
OBJECTIVE: Bilateral salpingo-oophorectomy (BSO) is the gold standard prophylactic
surgery for BRCA1 or 2 mutation carriers. However, due to the resulting early menopause and …
surgery for BRCA1 or 2 mutation carriers. However, due to the resulting early menopause and …
Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors
…, D Stoppa‐Lyonnet, P Vennin… - American Journal of …, 2000 - Wiley Online Library
Informed probands are key actors for disclosing genetic information to their relatives when a
mutation has been identified in the family. The objectives were to study women's attitudes …
mutation has been identified in the family. The objectives were to study women's attitudes …
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG–PET after the first course
…, L Vanlemmens, MC Baranzelli, P Vennin… - Breast cancer research …, 2012 - Springer
The aim of this study was to prospectively evaluate the predictive value of 18 F-fluorodeoxyglucose–positron
emission tomography (FDG–PET) to detect the absence of pathological …
emission tomography (FDG–PET) to detect the absence of pathological …
Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced …
…, V Dieras, J Chauvergne, P Vennin… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: To determine the efficacy and tolerability of irinotecan (CPT-11) in advanced or
recurrent cervical carcinoma. PATIENTS AND METHODS: Eligible patients had histologically …
recurrent cervical carcinoma. PATIENTS AND METHODS: Eligible patients had histologically …
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing
…, C Lasset, A Lortholary, TD N'Guyen, P Vennin… - European Journal of …, 2006 - Elsevier
The aim of this study was to assess the impact of a standardized patient information booklet
on decisions women make about genetic testing. This French national multi-centre survey …
on decisions women make about genetic testing. This French national multi-centre survey …
Surgical staging of early invasive epithelial ovarian tumors
…, A Chevalier, A Lesoin, P Vennin… - Seminars in surgical …, 2000 - Wiley Online Library
Early stage epithelial ovarian carcinoma is defined pathologically as a tumor strictly limited to
one or both ovaries without any extra‐ovarian disease (ie, Stage IA or B of the International …
one or both ovaries without any extra‐ovarian disease (ie, Stage IA or B of the International …
Patients' characteristics and rate of Internet use to obtain cancer information
…, A Lortholary, TD N'Guyen, P Vennin… - Journal of public …, 2006 - academic.oup.com
The aim of this study was to present baseline data on the access to Internet by French breast
cancer patients attending genetic clinics and to examine factors affecting Internet health-…
cancer patients attending genetic clinics and to examine factors affecting Internet health-…
[HTML][HTML] Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics
…, M Frenay, H Dreyfus, H Sobol, P Vennin… - Genetics in …, 2010 - nature.com
Purpose: To investigate the medical and psychosocial factors determining the time to
prophylactic surgery of unaffected women carriers of a deleterious BRCA1/2 mutation. Methods: …
prophylactic surgery of unaffected women carriers of a deleterious BRCA1/2 mutation. Methods: …
Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer
…, P Carpentier, P Depreux, P Vennin… - Journal of Nuclear …, 2000 - Soc Nuclear Med
Twenty-eight patients (12 men with prostate cancer, 16 women with breast cancer) were
included in a phase II trial to evaluate the efficacy of 186 Re-hydroxyethylidene diphosphonate (…
included in a phase II trial to evaluate the efficacy of 186 Re-hydroxyethylidene diphosphonate (…